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Background: Oral bone regeneration techniques (OBRT) attempt to provide the appropriate bone volume and den-
sity to correctly accomplish dental implant treatments. The objective was to determine whether differences exist 
in the clinical outcomes of these techniques between diabetic and non-diabetic patients, considering the level of 
scientific evidence. 
Material and Methods: A systematic review following PRISMA statements was conducted in the PubMed, Scopus 
and Cochrane databases with the search terms: “Diabetes Mellitus”, “guided bone regeneration”, “bone regenera-
tion”, “alveolar ridge augmentation”, “ridge augmentation”, bone graft*, “sinus floor augmentation”, “sinus floor 
elevation”, “sinus lift”, implant*. Articles were limited to those published less than 10 years ago and in English. 
Inclusion criteria were: human studies of all bone regeneration techniques, including at least 10 patients and the 
using OBRT in diabetic and non-diabetic patients. Non-human studies were excluded. They were stratified ac-
cording to their level of scientific evidence related to SORT criteria (Strength of Recommendation Taxonomy).
Results: The initial search provided 131 articles, after reading the abstracts a total of 33 relevant articles were 
selected to read the full text and analyzed to decide eligibility. Finally, seven of them accomplished the inclusion 
criteria: two controlled clinical trials, one cohort study and four case series. 
Conclusions: A low grade of evidence regarding the use of OBRT in diabetic patients was found. The recommen-
dation for this intervention in diabetic patients is considered type C due to the high heterogeneity of the type of 
diabetic patients included and the variability of the techniques applied.
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Introduction
Alveolar crest volume reduction is a common conse-
quence of tooth loss and can be, not only a difficulty for 
the treatment planning, but also a contraindication for 
dental implants placement. For this reason, bone aug-
mentation procedures may be required before implant 
therapy in areas with moderate to severe bone loss. 
Bone regeneration techniques, include alveolar bone 
augmentation (ABA), guided bone regeneration (GBR) 
and sinus lift (SL) procedures.
Systemic diseases including diabetes mellitus (DM) 
could be formally considered a contraindication (1–3) 
for these interventions, especially in case of associated 
implant installation, due to its vascular and immune de-
ficiencies. 
One of the most prevalent systemic diseases worldwide 
is diabetes mellitus (DM), a chronic metabolic disorder 
composed of two subtypes: Type 1 DM involves 5-10% 
of diabetic patients and is an autoimmune disorder re-
lated to the destruction of pancreatic β-cells and the 
consequent deficit in insulin production;  Type 2 DM, 
involves 90-95% of diabetic patients and is a multi-
factorial disease caused by environmental factors (e.g. 
obesity and sedentary lifestyle, corticosteroids intake) 
which lead to peripheral or cellular insulin resistance 
in genetically predisposed cases (4). The final result of 
decreased pancreatic production (type 1 DM) or periph-
eral cellular insensibility to insulin (type 2 DM) is an 
increase in blood glucose levels (hyperglycemia).  
Treatment in both types of DM is focused on achieving 
a proper glycemic control in order to prevent the devel-
opment of medical complications (3,5). In the long term, 
hyperglycemia promotes vascular complications which 
are one of the main causes of morbidity and mortality in 
this type of patients (6).
Chronic hyperglycemia also affects different tissue 
structures and produces an inflammatory effect, which 
results in a negative imbalance in the process of bone 
remodelation due to a decrease in bone formation rather 
than an increase in reabsorption as a consequence of 
the inhibitory effect of hyperglycemia on osteoblastic 
differentiation, impairment of parathyroid hormone 
activity which regulates phosphorus and calcium me-
tabolisms (7) and a reduction in adherence, growth and 
accumulation of the extracellular matrix, as it has been 
demonstrated in experimental models that mineral ho-
meostasis and osteoid production are significantly de-
creased in DM patients (6). Conversely, such models 
also showed that a persistent normoglycemic levels is 
directly correlated with an increased bone matrix and 
osteoid generation at a rate similar to controls, increas-
ing bone formation around the dental implants (6-9). 
DM patients with good glycemic control also demon-
strate a markedly reduced rate of periodontal bone loss, 
and a lower incidence of postoperative complications, 
compared to those with an inadequate one (3). Several 
studies have reported that the former group show suc-
cessful dental implant rates similar to non-DM patients 
(4,11). 
The main objective of this work was to review the cur-
rent literature, taking into account the level of scien-
tific evidence, to ascertain the rate of success of the oral 
bone regeneration techniques (OBRT) in DM patients.
Material and Methods
In October 2017 an electronic search was performed us-
ing PubMed, Scopus and Cochrane databases, follow-
ing the PRISMA statements (10), in order to answer the 
following PICO question:  “In patients with DM com-
pared with non-diabetics are there the same results of 
OBRT in terms of bone regeneration, complications and 
success of dental implants?”
The search was limited to articles published in English 
between 2007 and 2017 with the search terms: “diabetes 
mellitus”, “bone regeneration”, “guided bone regenera-
tion”, “alveolar ridge augmentation”, “bone graft*”, “si-
nus floor elevation” and “implant*”.  A second search 
was carried out employing Boolean operators such as 
“OR/AND” and synonyms of the keywords to obtain 
articles that included two or more of the terms. 
Finally, the Mesh Terms of the keywords were looked 
for, and a final search was performed: ((“Diabetes 
Mellitus”[Mesh]) AND (“guided bone regeneration” 
OR “bone regeneration” OR “alveolar ridge augmenta-
tion” OR “ridge augmentation” OR bone graft* OR “si-
nus floor augmentation” OR “sinus floor elevation” OR 
“sinus lift”)) AND implant*.
Inclusion criteria were: human studies, published in 
English from 2007 to 2017, regarding the use of OBRT 
in DM and non-DM patients. Exclusion criteria were 
non-human studies and case series including less than 
10 patients or case-control studies.
Articles were then stratified according to the level of 
scientific evidence using SORT criteria (11). On the ba-
sis of their scientific quality a grade of recommendation 
was given respect to the use OBRT in DM patients.
Results
The final electronic search performed on 31st October 
2017 provided 58 articles from Pubmed, 72 from Sco-
pus and 7 from Cochrane databases. Another three ar-
ticles were added after an additional hand search based 
on the references of the papers already found. 
After removing duplicates 131 articles were obtained, 
and after reading the abstracts, a total of 33 relevant ar-
ticles were identified and selected to read the full text. 
Finally  seven articles fulfilling inclusion criteria were 
included (1,5,12-16). The remaining 26 were excluded 
due to being descriptive studies (14,15), animal stud-
ies (16-24), no-DM patients (25), not performing bone 
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regeneration in the oral region (26) and not specifying 
whether OBRT was employed in DM patients (27–30).
The flow-chart of the review process modified from the 
PRISMA statement (10) is shown in Figure 1. Two out 
of the seven selected articles were controlled clinical 
trials  (1,5), one a retrospective cohort study  (12) and 
four were retrospective case series (13-16).
Fig. 1. Flow-chart of the review process modified from PRISMA statement (10).
The selected articles were classified according to the 
level of scientific evidence following SORT criteria (11): 
3 of scientific evidence level 2 (1,5,12), and the remain-
ing ones (13–16) of level 3. Table 1 summarizes the level 
of evidence of each study and the reasons for classifica-
tions.
Study design, duration, number of patients, gender, 
mean age, DM type, and OBRT applied are shown in 
Table 2. 
The main characteristics of each study: number of pa-
tients who underwent OBRT (DM patients and non-DM 
ones), number of implants placed in native and regen-
erated bone, evaluation technique, failure criteria, and 
results are synthetized in Tables 3 and 4. 
Regarding OBRT in DM patients the strength of recom-
mendation, on the basis of the level of evidence in the 
available data, is level C.  
Because the inconsistency of the patients’ characteris-
tics, the methodology used and parameters of compari-
son, it does not allow to carry on a methanalysis which 
could provide quantitative conclusions about the ben-
efits of OBRT in DM patients. Due to the high heteroge-
neity of the included studies it is not possible to perform 
a meta-analysis of the data.
Discussion 
Diabetic patients have an increased incidence of peri-
odontal disease and bone reabsorption (5), greater loss 
of alveolar bone (33,34) and more post-operative com-
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Level of scientific 
evidence (SORT)




Tawil et al. (1) Prospective CCT Small sample; variation in treatment procedures; dif-
ferent follow-up.
Edogan et al. (5) Prospective CCT Small sample; short-term follow-up; examiner of clini-
cal parameters not blinded; exclusion of 5 patients 
because of the absence of bone formation after OBRT.
Huynh et al. (12) Retrospective CS Type of DM not specified; variation in treatment 





Kaing et al. (13) Retrospective CR No systematic technique used; variation in treatment 
procedures; examiner not blinded.
Moreno Vazquez et al. 
(14)
Retrospective CR No systematic technique used; examiner not blinded.
Tran et al. (15) Retrospective CR No systematic technique used; variation in treatment 
procedures; examiner not blinded.
Hasegawa et al. (16) Retrospective CR No systematic technique used; variation in treatment 
procedures.
Table 1. Studies level of classification and the reasons for classification. CCT: controlled clinical trials, CR: case reports, CS: cohort study.
plications following implant placement surgery than 
non-DM ones (6). 
Due to this increased incidence of risk factors and 
complications, it has been shown that the success rate 
of dental implants in DM patients should be lower 
than in non-DM population (1,5,6,19), nevertheless, a 
good metabolic control can improve the survival rate 
of dental implants in such patients (1,3,6,20,21). Well-
controlled DM is therefore not considered a full con-
traindication for implant therapy even though current 
literature suggests a certain decrease in the success rate 
of concurrent surgical procedures as would be the case 
of OBRT (5).
In our review process it has been identified some studies 
evaluating the success of bone regeneration techniques 
in DM animals  (22–30), however, there were few re-
garding DM in humans despite the safety of performing 
implant therapy in such condition having been proven. 
Studies in non-controlled DM patients are even scarcer, 
probably due to the previously mentioned complications 
and ethical reasons. Only one publication with respect 
to OBR in non-controlled DM patients (HbA1c > 9%) 
was identified   and includes only one DM patient un-
derwent surgery (1). 
The regeneration techniques applied in the seven se-
lected studies for systematic review analysis include 
GBR, SL, and bone grafts. Out of the 7, only one (5) 
aimed at comparing OBRT clinical results in DM and 
non-DM patients. The objective of the remaining six 
was to identify the predictive failure factors of certain 
OBRTs (13,14) and for dental implants (1,12,16),  as well 
to compare dental implant survival rate between native 
and regenerated bone (15).
Some of these studies had a limited number of DM pa-
tients  and a marked disproportion between both groups 
(DM and non-DM) (12–14). In addition, relevant DM 
patient data were only specified in two articles regard-
ing illness duration, treatment applied to control the 
metabolic state, and pre/post-surgery HbA1c levels 
(1,5). Only Tawil et al. (1) considered the different gly-
cemic levels as a possible individual risk factor for im-
plant therapy and OBRT, concluding that HbA1c levels 
were the only multivariable and independent factor af-
fecting the rate of complication. 
On the other hand, as the principal aim of OBRT is to 
permit posterior implant therapy to be correctly per-
formed, it is difficult to clearly separate the implant 
success/failure or complication rates from each other 
(15,16), neither to compare OBRT   because there is no 
unified  methodology to evaluate the results. One study 
only specified the OBR procedures without detailing 
the implants placed later, as Kaaing et al. (13), or only 
described the implants placed in regenerated bone, ig-
noring the patients who underwent OBRT or the num-
ber of OBR procedures performed, as Tran et al.(15), 
Hasegawa et al. (16), and Tawil et al. (1).  Huynh et 
al. (12) report the number of patients who underwent 
OBRT, but do not specify whether they were DM or 
non-DM ones.
Tran et al. (15) and Hasegawa et al. (16)  counted the 
number of implants placed in native and regenerated 
bone and compared survival rates, without specifying 
Med Oral Patol Oral Cir Bucal. 2019 Jul 1;24 (4):e425-32.                                                                                                                                                          Bone regeneration in diabetic patients
e429
Author and year of 
publication
Study design Follow-up 
period
Number (n),
mean age (years) and 
gender of patients
DM type Technique and material of OBR




57 M and 36 F









DP: 52,6±7,3 yNDP: 
49.5±9.3




CM + 50% AB + 50% mixture of AB 
and synthetic bone substitute.





54.21 ±13.21 (16- 82)




G1: one-step antrostomy (28 impl)
G2: two-steps antrostomy (58 Impl)
G3: osteotome sinus floor–elevation 
technique. (30 Impl)
IO bovine (100 Impl)  and MRC in 
lateral window (37 Impl)












41 particulate BG and 45 block 
grafts.
- 64 AB.
- 4 bone substitute.
18 a combination of both.






50 M and 77 F
DM WC SL (202): modified Cadwell-Luck pro-
cedure.
- 55 block BG (115 Impl): 49 Onlay (93 
Impl) y 6 Inlay (22 Impl)
-147 particulate BG (249 Impl): 6 from 
cancellous tibia or iliac crest and 141 
bone recovered by filter.








That includes all the GBR, SL, 
and socket/ridge preservation 
techniques with BG including 
auto, allo, xenografts and al-
loplasts.










GBR: (739 Impl) CM
SL:(196 Impl)
Xenogeneic bone substitute mineral, 
bone replacement material, AB or 
mixture of these materials.
Table 2. Study design, duration, number of patients, gender, mean age, DM type, and OBRT applied.
AB: autogenous bone, BG: bone grafts, BRP: bone regeneration procedures, CCT: controlled clinical trials, CM: collagen membrane, CS: cohort 
study, DISR: dental implant survival rates, DM: diabetes mellitus, DM II: type 2 DM, DM WC: DM well-controlled metabolically, DM MC: 
DM moderately controlled, DM NC: DM non-controlled, DP: diabetic patients, F: females, G (1-3): groups 1-3, GBR: guided bone regeneration, 
m: months, M: males, NB: native bone, Impl: implants, NDP: non-diabetic patients, NS: not specified, OBR:  oral bone regeneration, SL: sinus 
lift, y: years. 























Implant loss. *95% confidence interval and 
significance level 0.05. 
• No differences between DP 
and NDP (P=0.66) Impl 
(P=0.81) in NB or OBR. 




DISR: DM WC (P=0.33) and DM 
BC: (P= 0.37) 
DISR = 97.2% (DP) and 98.8% 
(NDP). 
MBL: 0.41±0,58 mm (DP) and 
0.49±0,64 mm (NDP) 
DP 45 NS 143 112 













Absence of bone 
formation at the 
recipient cite. 
No alveolar width 
gain (1mm). 
Impl (1st year): pain, 
mobility, exudates 
history and > 2mm 
radiographic MBL 
from initial surgery. 
*0.5 of standard deviation in both 
groups and significance level 0.05 
• No differences between DP y 
NDP in: 
- Alveolar bone width gain. 
(P>0.05) 
- Histomorphometric analysis, 
RFA and wound-healing 
parameters. (P>0.05) 
• OBR success in DP=86% 
and NDP=80%. 
 
DISR = 100% (PD) y 100% (PND) 
TEI= 95% (PD) y 100% (PND) 
 
DP 12 15 0 22 





TOTAL 136 57 157 116 CE and R 
DISR. 






* Significance level 0.05. 
• DM is not a failure factor of 
Impl (in NB or OBR) (P<0.05.) 
 
DISR = 92.2% (OBR) y 
96.7%(NB). 
DIFR (NB and OBR); P=0.09 
DICR (NB and OBR); P=0.001 
DP 7 NS 10 9 
NDP 129 NS 147 107 
Table 3. Number of patients who underwent OBRT (DM patients and non-DM ones), number of implants placed in native and regenerated bone, 
evaluation technique, failure criteria, and results. 
BGSR: bone graft survival rates, CBCT: cone beam computed tomography, CE: clinical evaluation, DICR: dental implant complication rates, 
DIFR: dental implant failure rates, OPG: orthopantomogram, PC: postoperative complications, MBL: marginal bone loss, R: radiographs, SC: 
surgical complications.
the number of implants or techniques in both groups of 
patients. Huynh et al. (12) also calculated implant sur-
vival and success rates, specifying how many of each 
type were placed in DP and non-DP patients, and the 
total number who underwent OBRT. In the studies by 
Erdogan et al. (5) and Moreno Vazquez et al. (14) all 
the patients underwent OBRT and subsequent implant 
installation. Erdogan et al. (5) provide exact informa-
tion regarding the number of placed implants (all with 
OBRT) in DM and non-DM patients, while Moreno 
Vazquez et al. (14) do not specify the number of im-
plants placed in each group. In the case of Kaing et al. 
(13), all the patients had an OBRT and the study is fo-
cused on their results, without specifying the number of 
implants later inserted. Finally, in the study by Tawil et 
al. (1),  patients were divided into DM and non-DM, and 
in both groups implants were placed with and without 
OBRT. In this way, they could estimate the differences 
related to the results between implants installed in re-
generated bone and conventional ones in the two types 
of patients.
Finally, other factors contributing to the inconsistency 
of the results were: not mentioning or not classifying the 
bone defect, diagnostic methodology, and the criteria 
and methodology employed to evaluate the OBRT suc-
cess or failure. Nonetheless, one study (13) did report 
differences in OBRT results in DM patients compared 
to non-DM ones.

















 NB With 
OBRT 
Kaing et al. 
2011 
(13) 








failures, or any 
graft that had to be 
removed or 
regrafted for any 
reason. 
* Significance level 0.05. 
 
• DM is a failure 





DP 1 1 NS NS 





TOTAL 127 127 0 364 CE and R. PC. * Significance level 0.05. 
• No differences 
between groups. DP 2 2 0 NS 
NDP 125 125 0 NS 






TOTAL 1.222 NE 1819 910 CE of the 
implants; 
the absence 
or not of the 
implant at 
any point. 
All dental Impl 
that were removed 









• DM is not a failure 
factor of the Impl 
(with or without OBR) 
(P=0.07) 
 
DISR (5 years) = 90% 
(OBR) y 92% (NB). 
DISR (10 years) = 79% 
(OBR) y 87% (NB). 










et al. 2016 
(16) 















• DM does not 
affect MBL (in 
NB or OBR) 
(P=0.2044) 
 
DP 22 NE NE NE 
NDP 344 NE NE NE 
Table 4. Continuation of table 3. 
RFA: resonance frequency analysis.
Conclusions
As OBRT is a fairly new surgical intervention, and the 
available literature is not only scarce but extremely het-
erogeneous, it is not possible to categorically assert the 
reliability of this procedure in well-controlled DM pa-
tients. As consequence, and following the principles of 
evidence-based odontology, the present analysis reports 
a grade C of recommendation regarding its use.
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